Silk Road Medical, Inc

Equities

SILK

US82710M1009

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 21:00:00 21/06/2024 BST 5-day change 1st Jan Change
26.97 USD +0.04% Intraday chart for Silk Road Medical, Inc +26.09% +119.80%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Health Care Climbs Amid Deal Activity - Health Care Roundup DJ
Sector Update: Health Care Stocks Edge Up Late Afternoon MT
Sector Update: Health Care Stocks Edge Higher in Afternoon Trading MT
Sector Update: Health Care MT
Slowing Retail Sales Growth, Stronger Industrial Production Set Stage for Mixed Trading in US Equities MT
Top Midday Stories: Blackstone Makes $1.74 Billion Bid for Infocom; FDIC Expected to Downgrade Citigroup's 'Living Will'; Stellantis Unit to Recall Over 1 Million Vehicles MT
Silk Road Medical Shares Rally as Boston Scientific Plans Almost $1.2 Billion Acquisition MT
Lake Street Downgrades Silk Road Medical to Hold From Buy, Trims Price Target to $27.50 From $28 MT
Correction to Boston Scientific to Buy Silk Road Article DJ
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday MT
Traders Digest Retail Sales Data Ahead of Holiday Break, Driving Muted Premarket Action for US Equity Futures MT
Sector Update: Health Care MT
Top Premarket Gainers MT
Boston Scientific to Acquire Silk Road Medical for $27.50 Per Share MT
Silk Road Medical Shares Surge Premarket on Boston Scientific Deal DJ
Boston Scientific to Buy Silk Road Medical for About $1.26 Billion DJ
Boston Scientific Announces Agreement to Acquire Silk Road Medical RE
Silk Road Medical to Be Acquired by Boston Scientific in $1.26 Billion Deal MT
Boston Scientific to buy Silk Road Medical for $1.16 billion RE
Boston Scientific Announces Agreement to Acquire Silk Road Medical, Inc CI
Transcript : Silk Road Medical, Inc Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024
Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024
Earnings Flash (SILK) SILK ROAD MEDICAL Reports Q1 Revenue $48.5M, vs. Street Est of $44.7M MT
Silk Road Medical, Inc Provides Revenue Guidance for the Year 2024 CI
Silk Road Medical, Inc Provides Revenue Guidance for the Full Year 2024 CI
Chart Silk Road Medical, Inc
More charts
Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
26.97 USD
Average target price
21.4 USD
Spread / Average Target
-20.65%
Consensus
  1. Stock Market
  2. Equities
  3. SILK Stock
  4. News Silk Road Medical, Inc
  5. Argus Adjusts Silk Road Medical's Price Target to $55 From $70, Keeps Buy Rating